- Report
- March 2025
- 200 Pages
Global
From €4012EUR$4,490USD£3,537GBP
- Report
- February 2025
- 200 Pages
Global
From €4012EUR$4,490USD£3,537GBP
- Report
- January 2025
- 175 Pages
Global
From €4012EUR$4,490USD£3,537GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €894EUR$1,000USD£788GBP
€1117EUR$1,250USD£985GBP
- Report
- May 2025
- 142 Pages
Global
From €3529EUR$3,950USD£3,112GBP
- Report
- June 2025
- 400 Pages
Global
From €4422EUR$4,949USD£3,899GBP
- Report
- July 2025
- 350 Pages
Global
From €4422EUR$4,949USD£3,899GBP
- Report
- January 2025
- 176 Pages
Global
From €4463EUR$4,995USD£3,935GBP
- Report
- November 2025
- 160 Pages
Global
From €3529EUR$3,950USD£3,112GBP
- Report
- October 2025
- 160 Pages
Global
From €3529EUR$3,950USD£3,112GBP
- Report
- October 2025
- 160 Pages
Global
From €3529EUR$3,950USD£3,112GBP
- Report
- October 2025
- 160 Pages
Global
From €3529EUR$3,950USD£3,112GBP
- Report
- September 2025
- 150 Pages
Global
From €3440EUR$3,850USD£3,033GBP
- Report
- March 2025
- 85 Pages
Global
From €3500EUR$4,196USD£3,194GBP
- Report
- August 2025
- 150 Pages
Global
From €3440EUR$3,850USD£3,033GBP
- Report
- October 2025
- 150 Pages
Global
From €3440EUR$3,850USD£3,033GBP
- Report
- September 2025
- 150 Pages
Global
From €3440EUR$3,850USD£3,033GBP
- Report
- August 2025
- 150 Pages
Global
From €3440EUR$3,850USD£3,033GBP
- Report
- June 2025
- 150 Pages
Global
From €3440EUR$3,850USD£3,033GBP
€4334EUR$4,850USD£3,821GBP
- Clinical Trials
- April 2025
- 1432 Pages
Global
From €3083EUR$3,450USD£2,718GBP

Dermatitis is a broad term used to describe a range of skin conditions that cause inflammation, redness, and itching. It is a common skin disorder that affects people of all ages and can be caused by a variety of factors, including allergies, irritants, and infections. Treatment for dermatitis typically involves the use of topical medications, such as corticosteroids, antibiotics, and antihistamines. In some cases, phototherapy may be used to reduce inflammation.
The dermatitis market is an important part of the dermatology industry, as it is estimated that up to 20% of the population suffers from some form of dermatitis. The market is highly competitive, with a wide range of products available to treat the condition. Companies in the dermatitis market include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Novartis. Show Less Read more